Top Stock Losers
Explore the biggest stock losers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock losers and decliners every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
Globant's Q4 In Line With Expectations
JesterAI
|
Feb 26, 2025
The IT and software services company's earnings marginally beat analysts' forecast while revenue fell a hair short.
Why Shares of Travere Therapeutics Are Slumping Thursday
Jim Halley
|
Sep 21, 2023
A mixed trial could hurt a kidney drug's chances of full approval.
Why Shares of UroGen Pharma Jumped Friday
Jim Halley
|
Jul 28, 2023
The company released positive top-line results for two studies for a bladder cancer treatment.
Why Shares of Omeros Dropped on Monday
Jim Halley
|
Jun 12, 2023
The clinical-stage biopharmaceutical released trials data through a presentation.
Why Globant Stock Soared Today
Keith Noonan
|
May 19, 2023
Even after its recent rally, the software specialist's stock is still down approximately 53% from its high.
Could an FDA Approval Send This Stock Flying?
David Jagielski
|
Mar 1, 2023
Is now the time to load up on this struggling stock?
Why Travere Therapeutics Stock Bolted Higher This Week
George Budwell
|
Feb 23, 2023
A high-value regulatory approval lit a fire underneath the biotech's shares this week.
Why Omeros Stock Bolted Higher This Week
George Budwell
|
Feb 9, 2023
A $200 million milestone payment sparked a rally in the biopharma's shares this week.
Why Omeros Corporation Stock Is Skyrocketing Today
Keith Speights
|
Feb 6, 2023
The Omeros will now be able to fund operations at least through 2025.
Why Newegg Stock Was Down This Week
Demitri Kalogeropoulos
|
Sep 9, 2022
Sales trends are looking weak heading into the core holiday shopping period.
View More Articles